Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 1/2018

25.11.2017 | Review Article

Laser photocoagulation as treatment of non-exudative age-related macular degeneration: state-of-the-art and future perspectives

verfasst von: Giuseppe Querques, Maria Vittoria Cicinelli, Alessandro Rabiolo, Luigi de Vitis, Riccardo Sacconi, Lea Querques, Francesco Bandello

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To give an updated review of laser approaches to non-exudative age-related macular degeneration (AMD).

Methods

PubMed and Medline database searches were carried out using the terms “laser” and “photocoagulation” associated with “age-related macular degeneration”, and latest publications up to May 2017 have been reviewed. Moreover, the design of an ongoing single-center, non-randomized, phase I–II, pilot study, the PASCAL-GA trial, coordinated by F. Bandello, MD and G. Querques, MD from the IRCCS Ospedale San Raffaele, is described.

Results

Either standard or subthreshold laser strategies have been tried to induce regression of distinct phenotypes of AMD, as reticular pseudodrusen (RPD), nascent geographic atrophy (nGA), and drusen-associated geographic atrophy (DAGA), with heterogeneous results. The aim of the PASCAL-GA protocol is to assess if subthreshold laser can restore the retinal pigment epithelium function in eyes with RPD and nGA offering a protective effect against extensive GA.

Conclusions

New-generation medical and surgical approaches, including subthreshold laser photocoagulation, may have some success in downstaging AMD.
Literatur
1.
Zurück zum Zitat Bowling B (2016) Kanski’s clinical ophthalmology, 8th edn. Elsevier, Edinburgh Bowling B (2016) Kanski’s clinical ophthalmology, 8th edn. Elsevier, Edinburgh
3.
Zurück zum Zitat Ferris FL, Wilkinson CP, Bird A et al (2013) Clinical classification of age-related macular degeneration. Ophthalmology 120:844–851CrossRefPubMed Ferris FL, Wilkinson CP, Bird A et al (2013) Clinical classification of age-related macular degeneration. Ophthalmology 120:844–851CrossRefPubMed
4.
Zurück zum Zitat Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119:1417–1436CrossRefPubMedCentral Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119:1417–1436CrossRefPubMedCentral
5.
Zurück zum Zitat Lengyel I, Tufail A, Hosaini HA, Luthert P, Bird AC, Jeffery G (2004) Association of drusen deposition with choroidal intercapillary pillars in the aging human eye. Invest Ophthalmol Vis Sci 45:2886–2892CrossRefPubMed Lengyel I, Tufail A, Hosaini HA, Luthert P, Bird AC, Jeffery G (2004) Association of drusen deposition with choroidal intercapillary pillars in the aging human eye. Invest Ophthalmol Vis Sci 45:2886–2892CrossRefPubMed
6.
Zurück zum Zitat Mullins RF, Johnson MN, Faidley EA, Skeie JM, Huang J (2011) Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci 52:1606–1612CrossRefPubMedPubMedCentral Mullins RF, Johnson MN, Faidley EA, Skeie JM, Huang J (2011) Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci 52:1606–1612CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Klein ML, Ferris FL 3rd, Armstrong J, Hwang TS, Chew EY, Bressler SB, Chandra SR, AREDS Research Group (2008) Retinal precursors and the development of geographic atrophy in age-related macular degeneration. Ophthalmology 115:1026–1031CrossRefPubMed Klein ML, Ferris FL 3rd, Armstrong J, Hwang TS, Chew EY, Bressler SB, Chandra SR, AREDS Research Group (2008) Retinal precursors and the development of geographic atrophy in age-related macular degeneration. Ophthalmology 115:1026–1031CrossRefPubMed
8.
Zurück zum Zitat Boon CJ, van de Ven JP, Hoyng CB, den Hollander AI, Klevering BJ (2013) Cuticular drusen: stars in the sky. Prog Retin Eye Res 7:90–113CrossRef Boon CJ, van de Ven JP, Hoyng CB, den Hollander AI, Klevering BJ (2013) Cuticular drusen: stars in the sky. Prog Retin Eye Res 7:90–113CrossRef
9.
Zurück zum Zitat Arnold JJ, Sarks SH, Killingsworth MC et al (1995) Reticular pseudodrusen. A risk factor in age-related maculopathy. Retina 15:183–191CrossRefPubMed Arnold JJ, Sarks SH, Killingsworth MC et al (1995) Reticular pseudodrusen. A risk factor in age-related maculopathy. Retina 15:183–191CrossRefPubMed
10.
Zurück zum Zitat Zweifel SA, Imamura Y, Spaide TC et al (2010) Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology 117:1775–1781CrossRefPubMed Zweifel SA, Imamura Y, Spaide TC et al (2010) Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology 117:1775–1781CrossRefPubMed
11.
Zurück zum Zitat Zweifel SA, Spaide RF, Curcio CA, Malek G, Imamura Y (2010) Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology 117:303–312CrossRefPubMed Zweifel SA, Spaide RF, Curcio CA, Malek G, Imamura Y (2010) Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology 117:303–312CrossRefPubMed
12.
Zurück zum Zitat Querques G, Querques L, Forte R, Massamba N, Coscas F, Souied EH (2012) Choroidal changes associated with reticular pseudodrusen. Invest Ophthalmol Vis Sci 53:1258–1263CrossRefPubMed Querques G, Querques L, Forte R, Massamba N, Coscas F, Souied EH (2012) Choroidal changes associated with reticular pseudodrusen. Invest Ophthalmol Vis Sci 53:1258–1263CrossRefPubMed
13.
Zurück zum Zitat Corvi F, Souied EH, Capuano V, Costanzo E, Benatti L, Querques L, Bandello F, Querques G (2017) Choroidal structure in eyes with drusen and reticular pseudodrusen determined by binarisation of optical coherence tomographic images. Br J Ophthalmol 101:348–352 Corvi F, Souied EH, Capuano V, Costanzo E, Benatti L, Querques L, Bandello F, Querques G (2017) Choroidal structure in eyes with drusen and reticular pseudodrusen determined by binarisation of optical coherence tomographic images. Br J Ophthalmol 101:348–352
14.
Zurück zum Zitat Cicinelli MV, Rabiolo A, Marchese A et al (2017) Choroid morphometric analysis in non-neovascular age-related macular degeneration by means of optical coherence tomography angiography. Br J Ophthalmol 101:1193–1200 Cicinelli MV, Rabiolo A, Marchese A et al (2017) Choroid morphometric analysis in non-neovascular age-related macular degeneration by means of optical coherence tomography angiography. Br J Ophthalmol 101:1193–1200
15.
Zurück zum Zitat Querques G, Massamba N, Srour M, Boulanger E, Georges A, Souied EH (2014) Impact of reticular pseudodrusen on macular function. Retina 34:321–329CrossRefPubMed Querques G, Massamba N, Srour M, Boulanger E, Georges A, Souied EH (2014) Impact of reticular pseudodrusen on macular function. Retina 34:321–329CrossRefPubMed
16.
Zurück zum Zitat Querques G, Canouï-Poitrine F, Coscas F et al (2012) Analysis of progression of reticular pseudodrusen by spectral domain-optical coherence tomography. Invest Ophthalmol Vis Sci 53:1264–1270CrossRefPubMed Querques G, Canouï-Poitrine F, Coscas F et al (2012) Analysis of progression of reticular pseudodrusen by spectral domain-optical coherence tomography. Invest Ophthalmol Vis Sci 53:1264–1270CrossRefPubMed
17.
Zurück zum Zitat Wu Z, Luu CD, Ayton LN, Goh JK, Lucci LM, Hubbard WC, Hageman JL, Hageman GS, Guymer RH (2015) Fundus autofluorescence characteristics of nascent geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 56:1546–1552CrossRefPubMedPubMedCentral Wu Z, Luu CD, Ayton LN, Goh JK, Lucci LM, Hubbard WC, Hageman JL, Hageman GS, Guymer RH (2015) Fundus autofluorescence characteristics of nascent geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 56:1546–1552CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Moult EM, Waheed NK, Novais EA et al (2016) Swept-source optical coherence tomography angiography reveals choriocapillaris alterations in eyes with nascent geographic atrophy and drusen-associated geographic atrophy. Retina 36:S2–S11CrossRefPubMedPubMedCentral Moult EM, Waheed NK, Novais EA et al (2016) Swept-source optical coherence tomography angiography reveals choriocapillaris alterations in eyes with nascent geographic atrophy and drusen-associated geographic atrophy. Retina 36:S2–S11CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Wu Z, Luu CD, Ayton LN et al (2014) Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration. Ophthalmology 121:2415–2422CrossRefPubMed Wu Z, Luu CD, Ayton LN et al (2014) Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration. Ophthalmology 121:2415–2422CrossRefPubMed
20.
Zurück zum Zitat Gass JD (1971) Photocoagulation of macular lesions. Trans Am Acad Ophthalmol Otolaryngol 75:580–608PubMed Gass JD (1971) Photocoagulation of macular lesions. Trans Am Acad Ophthalmol Otolaryngol 75:580–608PubMed
21.
Zurück zum Zitat Priebe LA, Cain CP, Welch AJ (1975) Temperature rise required for production of minimal lesions in the Macaca Mulatta Retina. Am J Ophthalmol 79:405–413CrossRefPubMed Priebe LA, Cain CP, Welch AJ (1975) Temperature rise required for production of minimal lesions in the Macaca Mulatta Retina. Am J Ophthalmol 79:405–413CrossRefPubMed
22.
Zurück zum Zitat Stefansson E (1990) The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scand 79:435–440CrossRef Stefansson E (1990) The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scand 79:435–440CrossRef
23.
Zurück zum Zitat Macular Photocoagulation Study Group (1993) Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Arch Ophthalmol 111:1200–1209CrossRef Macular Photocoagulation Study Group (1993) Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Arch Ophthalmol 111:1200–1209CrossRef
24.
Zurück zum Zitat Ladas ID, Chatziralli IP, Kotsolis AI et al (2012) Intravitreal ranibizumab versus thermal laser photocoagulation in the treatment of extrafoveal classic choroidal neovascularization secondary to age-related macular degeneration. Ophthalmologica 228:93–101CrossRefPubMed Ladas ID, Chatziralli IP, Kotsolis AI et al (2012) Intravitreal ranibizumab versus thermal laser photocoagulation in the treatment of extrafoveal classic choroidal neovascularization secondary to age-related macular degeneration. Ophthalmologica 228:93–101CrossRefPubMed
25.
Zurück zum Zitat Duvall J, Tso MO (1985) Cellular mechanisms of resolution of drusen after laser coagulation. An experimental study. Arch Ophthalmol 103:694–703CrossRefPubMed Duvall J, Tso MO (1985) Cellular mechanisms of resolution of drusen after laser coagulation. An experimental study. Arch Ophthalmol 103:694–703CrossRefPubMed
26.
27.
Zurück zum Zitat Figueroa M, Schocket LS, DuPont J, Metelitsina TI, Grunwald JE (2006) Long-term effect of laser treatment for dry age-related macular degeneration on choroidal hemodynamics. Am J Ophthalmol 141:863–867CrossRefPubMed Figueroa M, Schocket LS, DuPont J, Metelitsina TI, Grunwald JE (2006) Long-term effect of laser treatment for dry age-related macular degeneration on choroidal hemodynamics. Am J Ophthalmol 141:863–867CrossRefPubMed
28.
Zurück zum Zitat Sigelman J (1991) Foveal drusen resorption one year after perifoveal laser photocoagulation. Ophthalmology 98:1379–1383CrossRefPubMed Sigelman J (1991) Foveal drusen resorption one year after perifoveal laser photocoagulation. Ophthalmology 98:1379–1383CrossRefPubMed
29.
Zurück zum Zitat Little HL, Showman JM, Brown BW (1997) A pilot randomized controlled study on the effect of laser photocoagulation of confluent soft macular drusen. Ophthalmology 104:623–631CrossRefPubMed Little HL, Showman JM, Brown BW (1997) A pilot randomized controlled study on the effect of laser photocoagulation of confluent soft macular drusen. Ophthalmology 104:623–631CrossRefPubMed
30.
Zurück zum Zitat Frennesson C, Nilsson SE (1998) Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications. Br J Ophthalmol 82:1169–1174CrossRefPubMedPubMedCentral Frennesson C, Nilsson SE (1998) Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications. Br J Ophthalmol 82:1169–1174CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Cleasby GW, Nakanishi AS, Norris JL (1979) Prophylactic photocoagulation of the fellow eye in exudative senile maculopathy. A preliminary report. Mod Probl Ophthalmol 20:141–147PubMed Cleasby GW, Nakanishi AS, Norris JL (1979) Prophylactic photocoagulation of the fellow eye in exudative senile maculopathy. A preliminary report. Mod Probl Ophthalmol 20:141–147PubMed
32.
Zurück zum Zitat Figueroa MS, Regueras A, Bertrand J, Aparicio MJ, Manrique MG (1997) Laser photocoagulation for macular soft drusen. Updated results. Retina 17:378–384CrossRefPubMed Figueroa MS, Regueras A, Bertrand J, Aparicio MJ, Manrique MG (1997) Laser photocoagulation for macular soft drusen. Updated results. Retina 17:378–384CrossRefPubMed
33.
Zurück zum Zitat Sarks SH, Arnold JJ, Sarks JP, Gilles MC, Walter CJ (1996) Prophylactic perifoveal laser treatment of soft drusen. Aust N Z J Ophthalmol 24:15–26CrossRefPubMed Sarks SH, Arnold JJ, Sarks JP, Gilles MC, Walter CJ (1996) Prophylactic perifoveal laser treatment of soft drusen. Aust N Z J Ophthalmol 24:15–26CrossRefPubMed
34.
Zurück zum Zitat Wetzig PC (1988) Treatment of drusen-related aging macular degeneration by photocoagulation. Trans Am Ophthalmol Soc 86:276–290PubMedPubMedCentral Wetzig PC (1988) Treatment of drusen-related aging macular degeneration by photocoagulation. Trans Am Ophthalmol Soc 86:276–290PubMedPubMedCentral
35.
Zurück zum Zitat Choroidal Neovascularization Prevention Trial Research Group (1998) Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial. Ophthalmology 105:11–23CrossRef Choroidal Neovascularization Prevention Trial Research Group (1998) Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial. Ophthalmology 105:11–23CrossRef
36.
Zurück zum Zitat Choroidal Neovascularization Prevention Trial Research Group (2003) Laser treatment in fellow eyes with large drusen: updated findings from a pilot randomized clinical trial. Ophthalmology 110:971–978CrossRef Choroidal Neovascularization Prevention Trial Research Group (2003) Laser treatment in fellow eyes with large drusen: updated findings from a pilot randomized clinical trial. Ophthalmology 110:971–978CrossRef
37.
Zurück zum Zitat Ho AC, Maguire MG, Yoken J et al (1999) Laser-induced drusen reduction improves visual function at 1 year. Choroidal Neovascularization prevention trial research group. Ophthalmology 106:1367–1374CrossRefPubMed Ho AC, Maguire MG, Yoken J et al (1999) Laser-induced drusen reduction improves visual function at 1 year. Choroidal Neovascularization prevention trial research group. Ophthalmology 106:1367–1374CrossRefPubMed
38.
Zurück zum Zitat Owens SL, Bunce C, Brannon AJ, Wormald R, Bird AC (2003) Drusen laser study group. Prophylactic laser treatment appears to promote choroidal neovascularization in high-risk ARM: results of an interim analysis. Eye (Lond) 17:623–627CrossRef Owens SL, Bunce C, Brannon AJ, Wormald R, Bird AC (2003) Drusen laser study group. Prophylactic laser treatment appears to promote choroidal neovascularization in high-risk ARM: results of an interim analysis. Eye (Lond) 17:623–627CrossRef
39.
Zurück zum Zitat Owens SL, Bunce C, Brannon AJ, Drusen Laser Study Group et al (2006) Prophylactic laser treatment hastens choroidal neovascularization in unilateral age-related maculopathy: final results of the drusen laser study. Am J Ophthalmol 141:276–281CrossRefPubMed Owens SL, Bunce C, Brannon AJ, Drusen Laser Study Group et al (2006) Prophylactic laser treatment hastens choroidal neovascularization in unilateral age-related maculopathy: final results of the drusen laser study. Am J Ophthalmol 141:276–281CrossRefPubMed
40.
Zurück zum Zitat Complications of Age-Related Macular Degeneration Prevention Trial Research Group (2006) Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial. Ophthalmology 113:1974–1986CrossRef Complications of Age-Related Macular Degeneration Prevention Trial Research Group (2006) Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial. Ophthalmology 113:1974–1986CrossRef
41.
Zurück zum Zitat Complications of Age-Related Macular Degeneration Prevention Trial Study Group (2004) The complications of age-related macular degeneration prevention trial (CAPT): rationale, design and methodology. Clin Trials 1:91–107CrossRef Complications of Age-Related Macular Degeneration Prevention Trial Study Group (2004) The complications of age-related macular degeneration prevention trial (CAPT): rationale, design and methodology. Clin Trials 1:91–107CrossRef
42.
Zurück zum Zitat Maguire M, Complications of Age-Related Macular Degeneration Prevention Trial Research Group (2004) Baseline characteristics, the 25-item National eye Institute visual functioning questionnaire, and their associations in the complications of age-related macular degeneration prevention trial (CAPT). Ophthalmology 111:1307–1316CrossRefPubMed Maguire M, Complications of Age-Related Macular Degeneration Prevention Trial Research Group (2004) Baseline characteristics, the 25-item National eye Institute visual functioning questionnaire, and their associations in the complications of age-related macular degeneration prevention trial (CAPT). Ophthalmology 111:1307–1316CrossRefPubMed
43.
Zurück zum Zitat Virgili G, Michelessi M, Parodi MB, Bacherini D, Evans JR (2015) Laser treatment of drusen to prevent progression to advanced age-related macular degeneration. Cochrane Database Syst Rev 10:CD006537PubMedCentral Virgili G, Michelessi M, Parodi MB, Bacherini D, Evans JR (2015) Laser treatment of drusen to prevent progression to advanced age-related macular degeneration. Cochrane Database Syst Rev 10:CD006537PubMedCentral
44.
Zurück zum Zitat Dorin G (2003) Subthreshold and micropulse diode laser photocoagulation. Semin Ophthalmol 18:147–153CrossRefPubMed Dorin G (2003) Subthreshold and micropulse diode laser photocoagulation. Semin Ophthalmol 18:147–153CrossRefPubMed
45.
Zurück zum Zitat Framme C, Brinkmann R, Birngruber R, Roider J (2002) Autofluorescence imaging after selective RPE laser treatment in macular diseases and clinical outcome: a pilot study. Br J Ophthalmol 86:1099–1106CrossRefPubMedPubMedCentral Framme C, Brinkmann R, Birngruber R, Roider J (2002) Autofluorescence imaging after selective RPE laser treatment in macular diseases and clinical outcome: a pilot study. Br J Ophthalmol 86:1099–1106CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Luttrull JK, Chang DB, Margolis BW, Dorin G, Luttrull DK (2015) Laser resensitization of medically unresponsive neovascular age-related macular degeneration: efficacy and implications. Retina 35:1184–1194CrossRefPubMed Luttrull JK, Chang DB, Margolis BW, Dorin G, Luttrull DK (2015) Laser resensitization of medically unresponsive neovascular age-related macular degeneration: efficacy and implications. Retina 35:1184–1194CrossRefPubMed
47.
Zurück zum Zitat Luttrull JK, Dorin G (2012) Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review. Curr Diabetes Rev 8:274–284CrossRefPubMedPubMedCentral Luttrull JK, Dorin G (2012) Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review. Curr Diabetes Rev 8:274–284CrossRefPubMedPubMedCentral
48.
Zurück zum Zitat Luttrull JK, Musch DC, Mainster MA (2005) Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema. Br J Ophthalmol 89:74–80CrossRefPubMedPubMedCentral Luttrull JK, Musch DC, Mainster MA (2005) Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema. Br J Ophthalmol 89:74–80CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Luttrull JK, Musch DC, Spink CA (2008) Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy. Eye (Lond) 22:607–612CrossRef Luttrull JK, Musch DC, Spink CA (2008) Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy. Eye (Lond) 22:607–612CrossRef
50.
Zurück zum Zitat Luttrull JK (2016) Low-intensity/high-density subthreshold diode micropulse laser for central serous Chorioretinopathy. Retina 36:1658–1663CrossRefPubMed Luttrull JK (2016) Low-intensity/high-density subthreshold diode micropulse laser for central serous Chorioretinopathy. Retina 36:1658–1663CrossRefPubMed
51.
Zurück zum Zitat Parodi MB, Spasse S, Iacono P, Di Stefano G, Canziani T, Ravalico G (2006) Subthreshold grid laser treatment of macular edema secondary to branch retinal vein occlusion with micropulse infrared (810 nanometer) diode laser. Ophthalmology 113:2237–2242CrossRefPubMed Parodi MB, Spasse S, Iacono P, Di Stefano G, Canziani T, Ravalico G (2006) Subthreshold grid laser treatment of macular edema secondary to branch retinal vein occlusion with micropulse infrared (810 nanometer) diode laser. Ophthalmology 113:2237–2242CrossRefPubMed
52.
Zurück zum Zitat Schuele G, Rumohr M, Huettmann G et al (2005) RPE damage thresholds and mechanisms for laser exposure in the microsecond-to-millisecond time regimen. Invest Ophthalmol Vis Sci 46:714–719CrossRefPubMed Schuele G, Rumohr M, Huettmann G et al (2005) RPE damage thresholds and mechanisms for laser exposure in the microsecond-to-millisecond time regimen. Invest Ophthalmol Vis Sci 46:714–719CrossRefPubMed
53.
Zurück zum Zitat Kim HD, Han JW, Ohn YH et al (2014) Functional evaluation using multifocal electroretinogram after selective retina therapy with a microsecond-pulsed laser. Invest Ophthalmol Vis Sci 56:122–131CrossRefPubMed Kim HD, Han JW, Ohn YH et al (2014) Functional evaluation using multifocal electroretinogram after selective retina therapy with a microsecond-pulsed laser. Invest Ophthalmol Vis Sci 56:122–131CrossRefPubMed
54.
Zurück zum Zitat Roider J, Brinkmann R, Wirbelauer C, Laqua H, Birngruber R (2000) Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study. Br J Ophthalmol 84:40–47CrossRefPubMedPubMedCentral Roider J, Brinkmann R, Wirbelauer C, Laqua H, Birngruber R (2000) Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study. Br J Ophthalmol 84:40–47CrossRefPubMedPubMedCentral
55.
Zurück zum Zitat Olk RJ, Friberg TR, Stickney K et al (1999) Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study. Ophthalmology 106:2082–2090CrossRefPubMed Olk RJ, Friberg TR, Stickney K et al (1999) Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study. Ophthalmology 106:2082–2090CrossRefPubMed
56.
Zurück zum Zitat Scorolli L, Corazza D, Morara M, Vismara S, Lugaresi ML, Meduri RA (2003) Argon laser vs. subthreshold infrared (810-nm) diode laser macular grid photocoagulation in nonexudative age-related macular degeneration. Can J Ophthalmol 38:489–495CrossRefPubMed Scorolli L, Corazza D, Morara M, Vismara S, Lugaresi ML, Meduri RA (2003) Argon laser vs. subthreshold infrared (810-nm) diode laser macular grid photocoagulation in nonexudative age-related macular degeneration. Can J Ophthalmol 38:489–495CrossRefPubMed
57.
Zurück zum Zitat Prahs P, Walter A, Regler R, Theisen-Kunde D, Birngruber R, Brinkmann R, Framme C (2010) Selective retina therapy (SRT) in patients with geographic atrophy due to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 248(5):651–658CrossRefPubMed Prahs P, Walter A, Regler R, Theisen-Kunde D, Birngruber R, Brinkmann R, Framme C (2010) Selective retina therapy (SRT) in patients with geographic atrophy due to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 248(5):651–658CrossRefPubMed
58.
Zurück zum Zitat Friberg TR, Brennen PM, Freeman WR, Musch DC, PTAMD Study Group (2009) Prophylactic treatment of age-related macular degeneration report number 2: 810-nanometer laser to eyes with drusen: bilaterally eligible patients. Ophthalmic Surg Lasers Imaging 40:530–538CrossRefPubMed Friberg TR, Brennen PM, Freeman WR, Musch DC, PTAMD Study Group (2009) Prophylactic treatment of age-related macular degeneration report number 2: 810-nanometer laser to eyes with drusen: bilaterally eligible patients. Ophthalmic Surg Lasers Imaging 40:530–538CrossRefPubMed
59.
Zurück zum Zitat Friberg TR, Musch DC, Lim JI, Morse L, Freeman W, Sinclair S, PTAMD Study Group (2006) Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients. Ophthalmology 113:622CrossRefPubMed Friberg TR, Musch DC, Lim JI, Morse L, Freeman W, Sinclair S, PTAMD Study Group (2006) Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients. Ophthalmology 113:622CrossRefPubMed
60.
Zurück zum Zitat Rodanant N, Friberg TR, Cheng L et al (2002) Predictors of drusen reduction after subthreshold infrared (810 nm) diode laser macular grid photocoagulation for nonexudative age-related macular degeneration. Am J Ophthalmol 134:577–585CrossRefPubMed Rodanant N, Friberg TR, Cheng L et al (2002) Predictors of drusen reduction after subthreshold infrared (810 nm) diode laser macular grid photocoagulation for nonexudative age-related macular degeneration. Am J Ophthalmol 134:577–585CrossRefPubMed
61.
Zurück zum Zitat Frennesson CI, Bek T, Jaakkola A, Nilsson SE, Prophylactic Laser Treatment Study Group (2009) Prophylactic laser treatment of soft drusen maculopathy: a prospective, randomized Nordic study. Acta Ophthalmol 87:720–724CrossRefPubMed Frennesson CI, Bek T, Jaakkola A, Nilsson SE, Prophylactic Laser Treatment Study Group (2009) Prophylactic laser treatment of soft drusen maculopathy: a prospective, randomized Nordic study. Acta Ophthalmol 87:720–724CrossRefPubMed
62.
Zurück zum Zitat Pankratov MM (1990) Pulsed delivery of laser energy in experimental thermal retinal photocoagulation. Proc Soc Photo Opt Instrum Eng 205–213 Pankratov MM (1990) Pulsed delivery of laser energy in experimental thermal retinal photocoagulation. Proc Soc Photo Opt Instrum Eng 205–213
63.
64.
Zurück zum Zitat Vujosevic S, Bottega E, Casciano M, Pilotto E, Convento E, Midena E (2010) Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. Retina 30:908–916CrossRefPubMed Vujosevic S, Bottega E, Casciano M, Pilotto E, Convento E, Midena E (2010) Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. Retina 30:908–916CrossRefPubMed
65.
Zurück zum Zitat Luttrull JK, Margolis BW (2016) Functionally guided retinal protective therapy for dry age-related macular and inherited retinal degenerations: a pilot study. Invest Ophthalmol Vis Sci 57:265–275CrossRefPubMed Luttrull JK, Margolis BW (2016) Functionally guided retinal protective therapy for dry age-related macular and inherited retinal degenerations: a pilot study. Invest Ophthalmol Vis Sci 57:265–275CrossRefPubMed
66.
Zurück zum Zitat Zhang JJ, Sun Y, Hussain AA, Marshall J (2012) Laser-mediated activation of human retinal pigment epithelial cells and concomitant release of matrix metalloproteinases. Invest Ophthalmol Vis Sci 53:2928–2937CrossRefPubMed Zhang JJ, Sun Y, Hussain AA, Marshall J (2012) Laser-mediated activation of human retinal pigment epithelial cells and concomitant release of matrix metalloproteinases. Invest Ophthalmol Vis Sci 53:2928–2937CrossRefPubMed
67.
Zurück zum Zitat Guymer RH, Brassington KH, Dimitrov P et al (2014) Nanosecond-laser application in intermediate AMD: 12-month results of fundus appearance and macular function. Clin Exp Ophthalmol 42:466–479CrossRefPubMed Guymer RH, Brassington KH, Dimitrov P et al (2014) Nanosecond-laser application in intermediate AMD: 12-month results of fundus appearance and macular function. Clin Exp Ophthalmol 42:466–479CrossRefPubMed
68.
Zurück zum Zitat Lek J, Brassington KH, Luu CD et al (2017) Laser in early stages of age-related macular degeneration study writing committee. Subthreshold nanosecond laser intervention in intermediate age-related macular degeneration. Ophthalmology Retina 3:227–239CrossRef Lek J, Brassington KH, Luu CD et al (2017) Laser in early stages of age-related macular degeneration study writing committee. Subthreshold nanosecond laser intervention in intermediate age-related macular degeneration. Ophthalmology Retina 3:227–239CrossRef
Metadaten
Titel
Laser photocoagulation as treatment of non-exudative age-related macular degeneration: state-of-the-art and future perspectives
verfasst von
Giuseppe Querques
Maria Vittoria Cicinelli
Alessandro Rabiolo
Luigi de Vitis
Riccardo Sacconi
Lea Querques
Francesco Bandello
Publikationsdatum
25.11.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 1/2018
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-017-3848-x

Weitere Artikel der Ausgabe 1/2018

Graefe's Archive for Clinical and Experimental Ophthalmology 1/2018 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.